SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-11-059627
Filing Date
2011-03-09
Accepted
2011-03-09 10:32:02
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-3 ds3.htm S-3 293555
2 FORM OF SENIOR DEBT INDENTURE dex42.htm EX-4.2 321710
3 FORM OF SUBORDINATED DEBT INDENTURE dex43.htm EX-4.3 322966
4 FORM OF COMMON STOCK WARRANT AGREEMENT dex46.htm EX-4.6 95064
5 FORM OF PREFERRED STOCK WARRANT AGREEMENT dex47.htm EX-4.7 97578
6 FORM OF DEBT SECURITIES WARRANT AGREEMENT dex48.htm EX-4.8 94311
7 OPINION OF COOLEY LLP dex51.htm EX-5.1 25991
8 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2687
9 GRAPHIC g159370g33w96.jpg GRAPHIC 2876
10 GRAPHIC g159370g53z14.jpg GRAPHIC 8930
  Complete submission text file 0001193125-11-059627.txt   1271591
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-172686 | Film No.: 11673920
SIC: 2835 In Vitro & In Vivo Diagnostic Substances